Riders · Department of State Health Services · Article II: Health and Human Services
HIV Care Formula Grants
Rider 27 in the 2024-25 Act, page II-33
This rider is not in the Introduced (Senate) or any later version.
Through the session
- 2024-25 Act In current law rider 27
- Introduced (Senate) Dropped
- Introduced (House) Not in this version
- Senate substitute Not in this version
- House substitute Not in this version
- House passed Not in this version
- Conference Not in this version
- 2026-27 Act Not in this version
Pick any two steps to compare their wording.
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | 27 | First version | — | Page II-33 |
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | Not in this version | |||
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | Not in this version | |||
| Senate substituteCommittee Substitute for Senate Bill 1 | Not in this version | |||
| House substituteHouse Committee Substitute for Senate Bill 1 | Not in this version | |||
| House passedSenate Bill 1 as passed the second house | Not in this version | |||
| ConferenceConference Committee Report for Senate Bill 1 | Not in this version | |||
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | Not in this version | |||
Full text of each wording
2024-25 Act
Source, page II-33HIV Care Formula Grants. If the projected expenses for the HIV Care Formula Grants as included in the Monthly Financial Report required by Rider 10, Other Reporting Requirements, require the Department of State Health Services to either expend HIV Care Formula Grants in excess of the appropriated amounts or expend a portion of the upcoming year’s award in the current fiscal year, DSHS shall provide the following information with their Monthly Financial Report:
(a) the amount of the future award to be expended in the current fiscal year;
(b) the reason for spending the funds early; and
(c) the effect of spending the funds early on funding availability in the following fiscal year.